Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants.
about
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant womenInfant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in uteroReduced mortality associated with breast-feeding-acquired HIV infection and breast-feeding among HIV-infected children in Zambia.Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs)Determinant factors of pregnant mothers' knowledge on mother to child transmission of HIV and its prevention in Gondar town, North West Ethiopia.Prevention of mother to child transmission of human immunodeficiency virus: the nigerian perspectiveRisk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine.Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).A trigger-based design for evaluating the safety of in utero antiretroviral exposure in uninfected children of human immunodeficiency virus-infected mothersAntiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant womenKnowledge of pregnant women on mother-to-child transmission of HIV, its prevention, and associated factors in Assosa town, Northwest Ethiopia.Update on successes and challenges regarding mother-to-child transmission of HIV.Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.Endocytic host cell machinery plays a dominant role in intracellular trafficking of incoming human immunodeficiency virus type 1 in human placental trophoblasts.Age and CD4 count of vertically HIV-infected children at the time of diagnosis: what are independent predictors for being symptomatic and CD4 counts drop?Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.Perinatally acquired HIV infection: long-term neuropsychological consequences and challenges ahead.Mother-to-child transmission of HIV in Brazil during the years 2000 and 2001: results of a multi-centric study.Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine and dideoxyinosine via maternal dosing, nursing, and direct gavage.Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth.Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.
P2860
Q24236763-FB82E856-1EEC-451D-BEAF-316236FC6359Q28392255-9A8B137D-A631-4BEE-87E5-5EBDC8B759A3Q33623586-1E75A345-0866-4AA9-BFB5-87D604B8908FQ34181048-B4CDF631-4CC4-4138-91DA-6F11A92AC84BQ34200645-70985F1B-2D05-49BC-919F-FFED7011A7C7Q34353931-F6403978-32DC-49AA-A25C-B735B77375C6Q34500949-26441F9B-93C7-4DFA-B876-31985DADC4B4Q34561354-13C6E8C2-FFE6-4B88-A8C0-D31B2FF67185Q35626381-993F8272-2A20-47CE-9A9C-463DD1B50BCCQ36077016-BB691226-7225-4042-9A09-8738A1B03FA5Q36438846-E2CEB560-02E4-4D9F-87AE-CB6E6FE88D11Q36803454-1FEC6EEC-84FE-4C61-8362-167D2F41FE2FQ36885242-69105CCE-9528-4D04-938D-495C2DA7016DQ37116460-AA491C32-DEFC-4ACB-9984-A2CFFB2C0F5FQ37148266-20B17AA2-3219-4ADE-89DC-427E2DF25DE5Q37583471-87D4066F-164F-40F9-9AEB-59A493696716Q37756416-D0D43CC5-B845-4AFD-B938-D76F0484728AQ37955240-3418768C-E631-4F7C-B3DA-DBF5BC797A13Q38201765-E854A60A-9097-460C-9493-7978CD69A9D2Q43999423-B1193A27-5AC4-45DF-8B45-FC903D182980Q44741992-883AB507-67CA-4153-BB72-826C736D0062Q45273875-17A17951-C4AA-46B7-9598-12DDA60CD48EQ45387049-A4875FDD-D23E-4868-BCDC-8F4D5576ACB4Q53850313-8714B94F-DA9E-42C7-9B33-FF6F1EB91362
P2860
Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Safety of antiretroviral proph ...... gnant women and their infants.
@ast
Safety of antiretroviral proph ...... gnant women and their infants.
@en
Safety of antiretroviral proph ...... gnant women and their infants.
@nl
type
label
Safety of antiretroviral proph ...... gnant women and their infants.
@ast
Safety of antiretroviral proph ...... gnant women and their infants.
@en
Safety of antiretroviral proph ...... gnant women and their infants.
@nl
prefLabel
Safety of antiretroviral proph ...... gnant women and their infants.
@ast
Safety of antiretroviral proph ...... gnant women and their infants.
@en
Safety of antiretroviral proph ...... gnant women and their infants.
@nl
P921
P1476
Safety of antiretroviral proph ...... gnant women and their infants.
@en
P2093
Lynne M Mofenson
Paula Munderi
P304
P356
10.1097/00042560-200206010-00010
P407
P577
2002-06-01T00:00:00Z